GLMD icon

Galmed Pharmaceuticals

19 hedge funds and large institutions have $25M invested in Galmed Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.

Holders
19
Holders Change
+8
Holders Change %
+72.73%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
4
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
6CM
1
683 Capital Management
New York
$5.94M 649,295 +100,000 +18%
MIH
2
Meitav Investment House
Israel
$4.36M 476,190 +476,190 New
NCM
3
Nantahala Capital Management
Connecticut
$3.66M 400,000 +400,000 New
PWAM
4
Park West Asset Management
California
$2.68M 292,847 +12,347 +4%
SFM
5
Sphera Funds Management
Israel
$2.16M 238,095 +238,095 New
II
6
Ibex Investors
Colorado
$2.08M 227,000 +227,000 New
Morgan Stanley
7
Morgan Stanley
New York
$1.53M 167,300 +45,900 +38%
PAWC
8
P.A.W. Capital
Connecticut
$961K 105,000
JGC
9
J. Goldman & Co
New York
$569K 62,200 +62,200 New
Renaissance Technologies
10
Renaissance Technologies
New York
$345K 37,705 +37,705 New
Deutsche Bank
11
Deutsche Bank
Germany
$246K 26,949 +26,949 New
EMG
12
ETF Managers Group
New Jersey
$119K 12,655 +12,655 New
CA
13
CapWealth Advisors
Tennessee
$109K 12,000
LNWWM
14
Laird Norton Wetherby Wealth Management
California
$92K 10,000
AAMU
15
Amundi Asset Management US
Massachusetts
$57K 6,200 +6,200 New
JPMorgan Chase & Co
16
JPMorgan Chase & Co
New York
$36K 3,980 +3,380 +563%
Macquarie Group
17
Macquarie Group
Australia
$8K 900 +900 New
UBS Group
18
UBS Group
Switzerland
$7K 736 +736 New
RFA
19
Reilly Financial Advisors
California
$2K 250
GL
20
GLG LLC
New York
-150,536 Closed
SKK
21
Shepherd Kaplan Krochuk
Massachusetts
-18,314 Closed
Acadian Asset Management
22
Acadian Asset Management
Massachusetts
-6,327 Closed